Key facts
- This page summarizes Peter C. Murphy's Form 4 filing for TELA Bio, Inc. (TELA).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Feb 2024, 16:35.
Peter C. Murphy - 23 Feb 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- TELA
- Reported as of
- 23 Feb 2024
- Net transaction value
- -$23,013
- SEC form
- 4
- Accepted by SEC
- 27 Feb 2024, 16:35:16 UTC
- Prior SEC filing
- 04 Apr 2023
- Next SEC filing
- 02 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Megan Smeykal, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Peter C. Murphy filed Form 4 for TELA Bio, Inc. (TELA) on 27 Feb 2024.
Change
- Previous filing in this sequence was filed on 04 Apr 2023.
- Current net transaction value: -$23,013.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TELA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +13,200
- Change %
- +34%
- Price
- $0.000000
- Shares after
- 51,547
- Date
- 23 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
TELA
transaction
Common Stock
Tax liability
- Transaction value
- $16,367
- Shares
- -2,315
- Change %
- -4.5%
- Price
- $7.07
- Shares after
- 49,232
- Date
- 23 Feb 2024
- Ownership
- Direct
- Footnotes
- F3
TELA
transaction
Common Stock
Tax liability
- Transaction value
- $6,646
- Shares
- -940
- Change %
- -1.9%
- Price
- $7.07
- Shares after
- 48,292
- Date
- 24 Feb 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TELA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +19,300
- Change %
- Price
- $0.000000
- Shares after
- 19,300
- Date
- 23 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,300
- Exercise price
- $7.07
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
Footnote F2
Includes 156 shares acquired under the Company's employee stock purchase plan on July 31, 2023 and 204 shares acquired under the Company's employee stock purchase plan on January 31, 2024.
Footnote F3
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
Footnote F4
The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.